BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 16816556)

  • 1. Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.
    Bonnet MM; Pinoges LL; Varaine FF; Oberhauser BB; O'Brien DD; Kebede YY; Hewison CC; Zachariah RR; Ferradini LL
    AIDS; 2006 Jun; 20(9):1275-9. PubMed ID: 16816556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.
    Rajasekaran S; Raja K; Jeyaseelan L; Vijilat S; Priya K; Mohan K; Parvez A; Mahilmaran A; Chandrasekar C
    Indian J Tuberc; 2009 Apr; 56(2):69-76. PubMed ID: 19810588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
    Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
    Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.
    Madec Y; Laureillard D; Pinoges L; Fernandez M; Prak N; Ngeth C; Moeung S; Song S; Balkan S; Ferradini L; Quillet C; Fontanet A
    AIDS; 2007 Jan; 21(3):351-9. PubMed ID: 17255742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low versus high CD4 cell count as starting point for introduction of antiretroviral treatment in resource-poor settings: a scenario-based analysis.
    Bogaards JA; Weverling GJ; Geskus RB; Miedema F; Lange JM; Bossuyt PM; Goudsmit J
    Antivir Ther; 2003 Feb; 8(1):43-50. PubMed ID: 12713063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007.
    Kwange SO; Budambula NL
    Indian J Med Microbiol; 2010; 28(1):21-5. PubMed ID: 20061758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
    Dheda K; Lampe FC; Johnson MA; Lipman MC
    J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources.
    Colebunders R; John L; Huyst V; Kambugu A; Scano F; Lynen L
    Int J Tuberc Lung Dis; 2006 Sep; 10(9):946-53. PubMed ID: 16964782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients.
    Lopez-Cortes LF; Marin-Niebla A; Lopez-Cortes LE; Villanego I; Rodriguez-Diez M; Pascual-Carrasco R
    Int J Tuberc Lung Dis; 2005 Dec; 9(12):1385-90. PubMed ID: 16466062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
    Pujades-Rodríguez M; O'Brien D; Humblet P; Calmy A
    AIDS; 2008 Jul; 22(11):1305-12. PubMed ID: 18580610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
    Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
    J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.
    Kassa A; Teka A; Shewaamare A; Jerene D
    Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):363-70. PubMed ID: 22521216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children.
    Zampoli M; Kilborn T; Eley B
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):417-23. PubMed ID: 17394688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status.
    Moreno S; Jarrin I; Iribarren JA; Perez-Elías MJ; Viciana P; Parra-Ruiz J; Gomez-Sirvent JL; Lopez-Aldeguer J; Gutierrez F; Blanco JR; Vidal F; Leal M; Rodríguez Arenas MA; Del Amo J;
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1393-400. PubMed ID: 19017448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
    Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
    AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reconstitution inflammatory syndrome in HIV-infected patients with tuberculosis.
    Kiertiburanakul S
    J Med Assoc Thai; 2010 Feb; 93(2):257-64. PubMed ID: 20302011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
    Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
    Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi.
    Glynn JR; Warndorff DK; Fine PE; Munthali MM; Sichone W; Pönnighaus JM
    Bull World Health Organ; 1998; 76(3):295-305. PubMed ID: 9744250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.